Rascol, Olivier
Article History
First Online: 19 August 2014
Competing interests
: The author has served as a scientific advisor for and received honoraria from AbbVie, Britannia, Boerhinger Ihghelheim, GlaxoSmithKline, Impax, Lundbeck, Novartis, Servier, Teva, UCB and Xenoport.